DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease

Carregando...
Imagem de Miniatura
Citações na Scopus
132
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
OLGIATI, Simone
QUADRI, Marialuisa
FANG, Mingyan
ROOD, Janneke P. M. A.
SAUTE, Jonas A.
BOUWKAMP, Christian G.
GRAAFLAND, Josja
MINNEBOO, Michelle
BREEDVELD, Guido J.
Citação
ANNALS OF NEUROLOGY, v.79, n.2, p.244-256, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
ObjectiveDNAJC6 mutations were recently described in two families with autosomal recessive juvenile parkinsonism (onset age<11), prominent atypical signs, poor or absent response to levodopa, and rapid progression (wheelchair-bound within approximate to 10 years from onset). Here, for the first time, we report DNAJC6 mutations in early-onset Parkinson's disease (PD). MethodsThe DNAJC6 open reading frame was analyzed in 274 patients with early-onset sporadic or familial PD. Selected variants were followed up by cosegregation, homozygosity mapping, linkage analysis, whole-exome sequencing, and protein studies. ResultsWe identified two families with different novel homozygous DNAJC6 mutations segregating with PD. In each family, the DNAJC6 mutation was flanked by long runs of homozygosity within highest linkage peaks. Exome sequencing did not detect additional pathogenic variants within the linkage regions. In both families, patients showed severely decreased steady-state levels of the auxilin protein in fibroblasts. We also identified a sporadic patient carrying two rare noncoding DNAJC6 variants possibly effecting RNA splicing. All these cases fulfilled the criteria for a clinical diagnosis of early-onset PD, had symptoms onset in the third-to-fifth decade, and slow disease progression. Response to dopaminergic therapies was prominent, but, in some patients, limited by psychiatric side effects. The phenotype overlaps that of other monogenic forms of early-onset PD. InterpretationOur findings delineate a novel form of hereditary early-onset PD. Screening of DNAJC6 is warranted in all patients with early-onset PD compatible with autosomal recessive inheritance. Our data provide further evidence for the involvement of synaptic vesicles endocytosis and trafficking in PD pathogenesis. Ann Neurol 2016;79:244-256
Palavras-chave
Referências
  1. Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373
  2. Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
  3. Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029
  4. Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005
  5. Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227
  6. Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
  7. Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
  8. Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9
  9. Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
  10. Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
  11. Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022
  12. Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
  13. Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415
  14. Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
  15. Vauthier V, 2012, MOL GENET METAB, V106, P345, DOI 10.1016/j.ymgme.2012.04.026
  16. Jiang JW, 2003, BIOCHEMISTRY-US, V42, P5748, DOI 10.1021/bi034270g
  17. Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6
  18. Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
  19. Koroglu C, 2013, PARKINSONISM RELAT D, V19, P320, DOI 10.1016/j.parkreldis.2012.11.006
  20. Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021
  21. UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0
  22. Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311
  23. Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022
  24. Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107
  25. Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185
  26. Kitada T, 1998, NATURE, V392, P605
  27. Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407
  28. McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
  29. Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043
  30. Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009
  31. Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
  32. Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
  33. Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372
  34. Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9
  35. Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418
  36. Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884
  37. Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023
  38. Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293
  39. Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215
  40. DisFonzo A, 2009, NEUROLOGY, V72, P240
  41. Edvardson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036458
  42. Foo JN, 2014, NEUROBIOL AGING, V35
  43. HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
  44. Ishikawa K, 1997, DNA Res, V4, P307, DOI 10.1093/dnares/4.5.307
  45. Jesus S, 2014, PARKINSONISM RELAT D, V20, P248, DOI 10.1016/j.parkreldis.2013.10.018
  46. Kononenko NL, 2015, NEURON, V85, P484, DOI 10.1016/j.neuron.2014.12.016
  47. Link Andrew J, 2011, Cold Spring Harb Protoc, V2011, P993, DOI 10.1101/pdb.prot5651
  48. Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021